Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Agonists of Toll-Like Receptors 3, 4, 7, and 9 Are Candidates for Use as Adjuvants in an Outer Membrane Vaccine againstNeisseria meningitidisSerogroup B
Floris Fransen, Claire J. P. Boog, Jos P. M. van Putten, et al.
Infection and Immunity (2007) Vol. 75, Iss. 12, pp. 5939-5946
Open Access | Times Cited: 63

Showing 1-25 of 63 citing articles:

Virulence and Immunomodulatory Roles of Bacterial Outer Membrane Vesicles
Terri N. Ellis, Meta Kuehn
Microbiology and Molecular Biology Reviews (2010) Vol. 74, Iss. 1, pp. 81-94
Open Access | Times Cited: 869
Use of defined TLR ligands as adjuvants within human vaccines
Malcolm S. Duthie, Hillarie Plessner Windish, Christopher B. Fox, et al.
Immunological Reviews (2010) Vol. 239, Iss. 1, pp. 178-196
Open Access | Times Cited: 414
Outer membrane vesicle vaccines
Francesca Micoli, Calman A. MacLennan
Seminars in Immunology (2020) Vol. 50, pp. 101433-101433
Open Access | Times Cited: 153
Naturally Produced Outer Membrane Vesicles fromPseudomonas aeruginosaElicit a Potent Innate Immune Response via Combined Sensing of Both Lipopolysaccharide and Protein Components
Terri N. Ellis, Sara A. Leiman, Meta Kuehn
Infection and Immunity (2010) Vol. 78, Iss. 9, pp. 3822-3831
Open Access | Times Cited: 224
Improved OMV vaccine against Neisseria meningitidis using genetically engineered strains and a detergent-free purification process
Bas van de Waterbeemd, Mathieu Streefland, Peter van der Ley, et al.
Vaccine (2010) Vol. 28, Iss. 30, pp. 4810-4816
Closed Access | Times Cited: 165
Triggering TLR7 in mice induces immune activation and lymphoid system disruption, resembling HIV-mediated pathology
Stefan Baenziger, Mathias Heikenwälder, Pål Johansen, et al.
Blood (2008) Vol. 113, Iss. 2, pp. 377-388
Open Access | Times Cited: 142
Engagement of TLR signaling as adjuvant: Towards smarter vaccine and beyond
Amit Lahiri, Priyanka Das, Dipshikha Chakravortty
Vaccine (2008) Vol. 26, Iss. 52, pp. 6777-6783
Closed Access | Times Cited: 140
Vaccination with Klebsiella pneumoniae-derived extracellular vesicles protects against bacteria-induced lethality via both humoral and cellular immunity
W. Lee, Hyun-Il Choi, Sung‐Wook Hong, et al.
Experimental & Molecular Medicine (2015) Vol. 47, Iss. 9, pp. e183-e183
Open Access | Times Cited: 129
Vaccination with Outer Membrane Complexes Elicits Rapid Protective Immunity to Multidrug-Resistant Acinetobacter baumannii
Michael J. McConnell, Juan Domínguez-Herrera, Younes Smani, et al.
Infection and Immunity (2010) Vol. 79, Iss. 1, pp. 518-526
Open Access | Times Cited: 127
OMV Vaccines and the Role of TLR Agonists in Immune Response
Francesca Mancini, Omar Rossi, Francesca Necchi, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 12, pp. 4416-4416
Open Access | Times Cited: 123
Vaccine-Induced Effector-Memory CD8+ T Cell Responses Predict Therapeutic Efficacy against Tumors
Suzanne van Duikeren, Marieke F. Fransen, Anke Redeker, et al.
The Journal of Immunology (2012) Vol. 189, Iss. 7, pp. 3397-3403
Open Access | Times Cited: 89
Selective TRIF-Dependent Signaling by a Synthetic Toll-Like Receptor 4 Agonist
William S. Bowen, Laurie A. Minns, David A. Johnson, et al.
Science Signaling (2012) Vol. 5, Iss. 211
Open Access | Times Cited: 76
Role of Bacterial Extracellular Vesicles in Manipulating Infection
Guanqi Zhao, Melissa K. Jones
Infection and Immunity (2023) Vol. 91, Iss. 5
Open Access | Times Cited: 20
Intradermal immunization improves protective efficacy of a novel TB vaccine candidate
Susan L. Baldwin, Sylvie Bertholet, Maria Kahn, et al.
Vaccine (2009) Vol. 27, Iss. 23, pp. 3063-3071
Open Access | Times Cited: 89
Potential adjuvantic properties of innate immune stimuli
Hemamali J. Warshakoon, Jennifer D. Hood, Matthew R. Kimbrell, et al.
Human Vaccines (2009) Vol. 5, Iss. 6, pp. 381-394
Open Access | Times Cited: 78
Adjuvant properties of meningococcal outer membrane vesicles and the use of adjuvants inNeisseria meningitidisprotein vaccines
Holly Sanders, Ian M. Feavers
Expert Review of Vaccines (2011) Vol. 10, Iss. 3, pp. 323-334
Closed Access | Times Cited: 64
Optimization of an Experimental Vaccine To Prevent Escherichia coli Urinary Tract Infection
Valerie S. Forsyth, Stephanie D. Himpsl, Sara N. Smith, et al.
mBio (2020) Vol. 11, Iss. 2
Open Access | Times Cited: 47
Exploiting bacterial outer membrane vesicles as a cross-protective vaccine candidate against avian pathogenic Escherichia coli (APEC)
Rujiu Hu, Jing Li, Yuezhen Zhao, et al.
Microbial Cell Factories (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 41
Selection of combination adjuvants for enhanced immunogenicity of a recombinant CelTOS vaccine against Plasmodium falciparum
Sakineh Pirahmadi, Mostafa Zargar, Zeinab Pourhashem, et al.
Biochemical and Biophysical Research Communications (2025) Vol. 748, pp. 151310-151310
Closed Access
Evaluation of a Whole-Blood Cytokine Release Assay for Use in Measuring Endotoxin Activity of Group B Neisseria meningitidis Vaccines Made from Lipid A Acylation Mutants
Mark B. Stoddard, Valerian B. Pinto, Paul B. Keiser, et al.
Clinical and Vaccine Immunology (2009) Vol. 17, Iss. 1, pp. 98-107
Open Access | Times Cited: 57
B cell TLRs and induction of immunoglobulin class-switch DNA recombination
Egest J. Pone, Zhenming Xu, Clayton A. White, et al.
Frontiers in bioscience (2012) Vol. 17, Iss. 7, pp. 2594-2594
Open Access | Times Cited: 56
Preclinical safety and immunogenicity evaluation of a nonavalent PorA native outer membrane vesicle vaccine against serogroup B meningococcal disease
Patricia Kaaijk, Ineke van Straaten, Bas van de Waterbeemd, et al.
Vaccine (2012) Vol. 31, Iss. 7, pp. 1065-1071
Closed Access | Times Cited: 50
Identification of immunogenic outer membrane vesicle vaccine antigen components using a meningococcal protein microarray
Fidel Ramírez Bencomo, Angela Thistlethwaite, Vadim R. Viviani, et al.
Vaccine (2025) Vol. 53, pp. 126953-126953
Open Access
Differential Effect of TLR2 and TLR4 on the Immune Response after Immunization with a Vaccine against Neisseria meningitidis or Bordetella pertussis
Floris Fransen, Rachel M. Stenger, Martien C. M. Poelen, et al.
PLoS ONE (2010) Vol. 5, Iss. 12, pp. e15692-e15692
Open Access | Times Cited: 44
TLR agonist combinations that stimulate Th type I polarizing responses from human neonates
Naveen Surendran, Andrea Megela Simmons, Michael E. Pichichero
Innate Immunity (2018) Vol. 24, Iss. 4, pp. 240-251
Open Access | Times Cited: 35
Page 1 - Next Page

Scroll to top